Regulation of the CD4 + T cell allo-immune response by endothelial cells
Human Immunology, ISSN: 0198-8859, Vol: 73, Issue: 12, Page: 1269-1274
2012
- 17Citations
- 30Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations17
- Citation Indexes17
- CrossRef17
- 15
- Captures30
- Readers30
- 30
Article Description
Recent studies have revealed the presence of pro-inflammatory and/or regulatory CD4 + T cells within allografts promoting either graft rejection or tolerance. Histological evidence has identified the microvascular endothelium as the primary site of allograft damage as it is the first site of encounter with the recipient’s immune system. The initial view of the human endothelial cell inducing an effector Th1 response leading to graft rejection has been extended by recent results which demonstrate the endothelial cell ability to generate other CD4 + T cell sub-populations including Th17 and Treg cells. In the transplantation setting, the allo-reactivity of the endothelium with the CD4 + T cell populations is likely to depend upon multiple factors including the vascular origin of the endothelial cell, the cytokine environment, the presence or absence of pro-inflammatory stimuli including ligands of Toll like receptors and alloantibodies. This review provides an update on the characteristics of the endothelial cell activation of the CD4 + T cell response and an analysis of the factors, which can modify this activity in favor of either graft rejection or tolerance.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0198885912001656; http://dx.doi.org/10.1016/j.humimm.2012.07.009; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84869086456&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/22813652; https://linkinghub.elsevier.com/retrieve/pii/S0198885912001656; https://dx.doi.org/10.1016/j.humimm.2012.07.009
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know